Get the Stockscreener App
36.88
0.38%
-0.02
After Hours:
36.84
-0.04
-0.11%
Apogee Therapeutics Inc stock is traded at $36.88, with a volume of 261.14K.
It is down -0.38% in the last 24 hours and down -1.53% over the past month.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
See More
Previous Close:
$36.86
Open:
$36.77
24h Volume:
261.14K
Relative Volume:
0.33
Market Cap:
$1.70B
Revenue:
-
Net Income/Loss:
$-146.66M
P/E Ratio:
-13.39
EPS:
-2.7541
Net Cash Flow:
$-133.21M
1W Performance:
-4.52%
1M Performance:
-1.53%
6M Performance:
-8.06%
1Y Performance:
-28.70%
1-Day Range:
$36.28
$37.87
1-Week Range:
$36.01
$38.75
52-Week Range:
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
Name
Apogee Therapeutics Inc
Sector
Industry
Phone
650-394-5230
Address
221 CRESCENT ST., WALTHAM
Compare APGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
36.88 | 2.20B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.34 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.02 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.33 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Reiterated | BTIG Research | Buy |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Nov-25-24 | Initiated | Canaccord Genuity | Buy |
| May-10-24 | Initiated | BofA Securities | Buy |
| Dec-20-23 | Initiated | BTIG Research | Buy |
| Aug-08-23 | Initiated | Guggenheim | Buy |
| Aug-08-23 | Initiated | Jefferies | Buy |
| Aug-08-23 | Initiated | Stifel | Buy |
| Aug-08-23 | Initiated | TD Cowen | Outperform |
| Aug-08-23 | Initiated | Wedbush | Outperform |
View All
Apogee Therapeutics Inc Stock (APGE) Latest News
Aug Ideas: Is Apogee Therapeutics Inc. a top pick in the sectorIPO Watch & Precise Swing Trade Entry Alerts - خودرو بانک
Apogee Therapeutics Inc. $APGE Shares Sold by Siren L.L.C. - MarketBeat
VIX Spike: Can Apogee Therapeutics Inc outperform under higher oil pricesTrade Entry Summary & Short-Term Trading Alerts - خودرو بانک
Market Catalysts: Is Apogee Therapeutics Inc exposed to currency risks2025 Price Action Summary & Verified Swing Trading Watchlist - خودرو بانک
Stock Market Recap: Is Apogee Therapeutics Inc attractive for institutional investorsWall Street Watch & Fast Exit and Entry Strategy Plans - خودرو بانک
Aug Wrap: Is Apogee Therapeutics Inc stock a value trap2025 Trade Ideas & AI Powered Buy/Sell Recommendations - خودرو بانک
Evaluating Apogee Therapeutics Inc. with trendline analysisShort Setup & Weekly Market Pulse Updates - newser.com
Will earnings trigger a reversal in Apogee Therapeutics Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
Is Apogee Therapeutics Inc. forming a bottoming base2025 Technical Patterns & Intraday High Probability Alerts - newser.com
Is Apogee Therapeutics Inc. stock reversal real or fakeQuarterly Risk Review & Daily Price Action Insights - newser.com
Is Apogee Therapeutics Inc. stock ready for a breakoutJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis - Yahoo Finance
How to build a custom watchlist for Apogee Therapeutics Inc.Market Trend Summary & Entry Point Confirmation Alerts - newser.com
Octagon Capital Advisors LP Takes $399.75 Million Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Is Apogee Therapeutics Inc. showing signs of accumulationQuarterly Trade Summary & Community Consensus Trade Signals - newser.com
Is Apogee Therapeutics Inc. still worth holding after the dip2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
Apogee Therapeutics Inc. stock trendline breakdown2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
How hedge fund analytics apply to Apogee Therapeutics Inc. stockJuly 2025 WrapUp & Daily Volume Surge Signals - newser.com
Woodline Partners LP Has $39.64 Million Stock Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Multi asset correlation models including Apogee Therapeutics Inc.July 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
Has Apogee Therapeutics Inc. formed a bullish divergenceJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com
What machine learning models say about Apogee Therapeutics Inc.2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Should you hold or exit Apogee Therapeutics Inc. nowQuarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Alliancebernstein L.P. Decreases Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Parkman Healthcare Partners LLC Reduces Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics Announces Late-Breaker Presentation of - GlobeNewswire
Apogee Therapeutics Announces Acceptance of Phase 2 APEX Trial Data for APG777 at EADV Congress 2025 - Quiver Quantitative
Apogee Therapeutics to present 16-week phase 2 data on APG777 for atopic dermatitis at EADV 2025 - MarketScreener
Apogee Therapeutics Announces Late-Breaker Presentation of 16-Week Data from Phase 2 APEX Trial of APG777 for Moderate-to-Severe Atopic Dermatitis at the Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress - GlobeNewswire
First 3-6 Month Dosing Biologic: Apogee's APG777 Shows Best-in-Class Potential for Atopic Dermatitis - Stock Titan
Apogee Therapeutics Inc. $APGE Shares Sold by Northern Trust Corp - MarketBeat
Adage Capital Partners GP L.L.C. Acquires 486,800 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat
Granahan Investment Management LLC Buys 15,486 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat
Relief Rally in Apogee Therapeutics Inc. Stock — Can It Hold2025 Technical Patterns & Reliable Breakout Forecasts - beatles.ru
Apogee Therapeutics Inc. $APGE Shares Acquired by Allostery Investments LP - MarketBeat
Birchview Capital LP Makes New Investment in Apogee Therapeutics Inc. $APGE - MarketBeat
Is Apogee Therapeutics Inc. stock technically oversold2025 Volatility Report & AI Forecast Swing Trade Picks - 강소기업뉴스
Apogee Therapeutics Inc. $APGE Shares Sold by Corebridge Financial Inc. - Defense World
ADAR1 Capital Management LLC Has $3.92 Million Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat
Technical analysis overview for Apogee Therapeutics Inc. stockGold Moves & Reliable Entry Point Alerts - Newser
Does Apogee Therapeutics Inc. meet Warren Buffett’s criteriaWeekly Stock Analysis & Daily Profit Maximizing Tips - خودرو بانک
Rafferty Asset Management LLC Decreases Stock Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Chart Patterns Forming a Bullish Setup in Apogee Therapeutics Inc.2025 Valuation Update & Expert Approved Trade Ideas - beatles.ru
Apogee Therapeutics CMO sells $103,198 in stock By Investing.com - Investing.com Canada
Can technical indicators confirm Apogee Therapeutics Inc.’s reversalJuly 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Using data models to predict Apogee Therapeutics Inc. stock movement2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Relative strength of Apogee Therapeutics Inc. in sector analysisRate Cut & Weekly Breakout Watchlists - Newser
Is Apogee Therapeutics Inc. subject to activist investor interestProfit Target & High Return Trade Opportunity Guides - خودرو بانک
Is Apogee Therapeutics Inc. stock overvalued or fairly pricedJuly 2025 Short Interest & Stepwise Trade Execution Plans - خودرو بانک
Earnings visualization tools for Apogee Therapeutics Inc.2025 Growth vs Value & AI Enhanced Trading Signals - Newser
AlphaQuest LLC Takes Position in Apogee Therapeutics Inc. $APGE - Defense World
Apogee Therapeutics Inc Stock (APGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Apogee Therapeutics Inc Stock (APGE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer |
Aug 06 '25 |
Sale |
37.78 |
2,725 |
102,950 |
236,273 |
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Option Exercise |
22.86 |
7,365 |
168,364 |
249,088 |
| Dambkowski Carl | Chief Medical Officer |
Jul 02 '25 |
Sale |
45.09 |
10,090 |
454,954 |
238,998 |
0.58%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):